Your browser doesn't support javascript.
loading
Persistent hypertension among postpartum women with comorbid HIV and preeclampsia in Zambia.
Mukosha, Moses; Hatcher, Abigail; Lubeya, Mwansa Ketty; Maposa, Innocent; Chi, Benjamin H; Mutale, Wilbroad.
Afiliação
  • Mukosha M; Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Hatcher A; Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Lubeya MK; Department of Obstetrics and Gynaecology, University of Zambia, Lusaka, Zambia.
  • Maposa I; Department of Global Health, Division of Epidemiology & Biostatistics, Stellenbosch University, Cape Town, South Africa.
  • Chi BH; Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States of America.
  • Mutale W; Department of Health Policy and Management, University of Zambia, Lusaka, Zambia.
PLoS One ; 19(9): e0309915, 2024.
Article em En | MEDLINE | ID: mdl-39231156
ABSTRACT

BACKGROUND:

Persistent hypertension is common after preeclampsia and is causally tied to later cardiovascular risks. This study examined whether being HIV-infected and on antiretroviral therapy (ART) is associated with persistent postpartum hypertension among women diagnosed with preeclampsia.

METHODS:

We conducted a six-month prospective cohort study at Kanyama and Women and Newborn hospitals from January 01, 2022, to June 30, 2023, among 190 women diagnosed with preeclampsia (59 HIV-positive, 131 HIV-negative). Sociodemographic and clinical characteristics were collected at delivery, six weeks, three months and six months after giving birth. Persistent hypertension was diagnosed if a participant presented with elevated blood pressure ≥140mmHg and/or diastolic blood pressure ≥90mmHg and/or taking medication for hypertension at the study visit. We used a generalized estimating equation to describe the relationship between treated HIV and persistent hypertension six months following delivery.

RESULTS:

We retained 136 participants (71.6%) to six months postpartum, at a median age of 30 years. Overall, persistent hypertension at six weeks, three months, and six months postpartum was common (37.4%, 17.1% and 16.9%, respectively). Six-week postpartum prevalence was higher in the HIV group than HIV-negative group (54.6% vs 28.8%, p<0.001), with no measurable difference at three months (24.3% vs 13.2%, p = 0.145) or six months (18.2% vs 16.3%, p = 0.787). Multivariable analysis demonstrates higher odds (adjusted odds ratio [aOR] = 1.68, 95% CI 1.09-2.60) of persistent hypertension among the HIV+treatment group than HIV-negative counterparts after accounting for age, body mass index and time since delivery.

CONCLUSION:

We demonstrate an elevated risk of persistent hypertension among postpartum women with comorbid preeclampsia and treated HIV. Peripartum patients in HIV-endemic settings may benefit from timely detection of hypertension and treatment interventions to improve health outcomes.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pré-Eclâmpsia / Infecções por HIV / Período Pós-Parto / Hipertensão Limite: Adult / Female / Humans / Pregnancy País/Região como assunto: Africa Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pré-Eclâmpsia / Infecções por HIV / Período Pós-Parto / Hipertensão Limite: Adult / Female / Humans / Pregnancy País/Região como assunto: Africa Idioma: En Ano de publicação: 2024 Tipo de documento: Article